Schizophrenia

>

The HCPLive schizophrenia page is a resource for medical news and expert insights on the mental disorder. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for schizophrenia, and more.

Latest News

[Human brain activity with plexus lines] I Image credit: vegefox.com - Adobe Stock
Schizophrenia with Violence Linked to Reduced Left Frontal Gray Matter, Higher TSH

November 29th 2024

A study found patients with schizophrenia exhibiting violence, vs. those who don’t, have less gray matter volume in the frontal lobe and greater thyroid-stimulating hormone levels.

Mindfulness-Based Intervention Significantly Reduces Psychotic Symptoms
Mindfulness-Based Intervention Significantly Reduces Psychotic Symptoms

November 27th 2024

Study Shows Many with Treatment-Resistant Schizophrenia Have a Poor Diet
Study Shows Many with Treatment-Resistant Schizophrenia Have a Poor Diet

November 26th 2024

Can Antipsychotics Increase Mortality Risk? A New Study Shows It Might
Can Antipsychotics Increase Mortality Risk? A New Study Shows It Might

November 26th 2024

Study Identifies Homelessness as a Predictor Against Clozapine Use
Study Identifies Homelessness as a Predictor Against Clozapine Use

November 22nd 2024

More News

Jelena Kunovac, MD: Decreased Schizophrenia Screenings During COVID-19

Jelena Kunovac, MD: Decreased Schizophrenia Screenings During COVID-19

June 1st 2020

More prospective studies are needed to examine how different drugs can be effective for schizophrenia patients based on the cluster of symptoms.

Jelena Kunovac, MD: The Difficulty of Treating Schizophrenia

Jelena Kunovac, MD: The Difficulty of Treating Schizophrenia

May 31st 2020

Antipsychotic discontinuation remains a major hurdle for effective schizophrenia treatment.

Jelena Kunovac, MD: Aripiprazole Lauroxil to Treat Schizophrenia

Jelena Kunovac, MD: Aripiprazole Lauroxil to Treat Schizophrenia

May 29th 2020

The results of a phase 3B study show the medication is effective treating the disorder despite only needing to be taken once every 8 weeks.

Schizophrenia Treatment and Outlook

Schizophrenia Treatment and Outlook

May 28th 2020
Schizophrenia Treatment: Overcoming Obstacles

Schizophrenia Treatment: Overcoming Obstacles

May 28th 2020
Patient-Physician Collaboration and Schizophrenia Outcomes

Patient-Physician Collaboration and Schizophrenia Outcomes

May 28th 2020
LAI Treatment Selection and Patient Factors

LAI Treatment Selection and Patient Factors

May 28th 2020
Second-Generation LAIs for Schizophrenia

Second-Generation LAIs for Schizophrenia

May 28th 2020
Current LAI Options for Schizophrenia

Current LAI Options for Schizophrenia

May 28th 2020
Early Initiation of LAI Therapy for Schizophrenia

Early Initiation of LAI Therapy for Schizophrenia

May 28th 2020
Dosing LAI Antipsychotics for Schizophrenia

Dosing LAI Antipsychotics for Schizophrenia

May 28th 2020
Advantages of LAI Antipsychotics for Schizophrenia

Advantages of LAI Antipsychotics for Schizophrenia

May 28th 2020
NCBH Guidelines and LAI Therapy for Schizophrenia

NCBH Guidelines and LAI Therapy for Schizophrenia

May 28th 2020
Misperceptions and Underutilization of LAIs for Schizophrenia

Misperceptions and Underutilization of LAIs for Schizophrenia

May 28th 2020
Barriers to Prescribing LAIs for Schizophrenia

Barriers to Prescribing LAIs for Schizophrenia

May 28th 2020
Long-Acting Injectable Antipsychotics for Schizophrenia

Long-Acting Injectable Antipsychotics for Schizophrenia

May 28th 2020
Challenges With Oral Antipsychotics for Schizophrenia

Challenges With Oral Antipsychotics for Schizophrenia

May 28th 2020
Psychosocial Interventions for Schizophrenia

Psychosocial Interventions for Schizophrenia

May 28th 2020
Socioeconomic Burden of Treatment Adherence in Schizophrenia

Socioeconomic Burden of Treatment Adherence in Schizophrenia

May 28th 2020
Treatment Nonadherence and Schizophrenia Relapses

Treatment Nonadherence and Schizophrenia Relapses

May 28th 2020
Schizophrenia Relapses and Patient Well-Being

Schizophrenia Relapses and Patient Well-Being

May 28th 2020
Counseling Patients With Schizophrenia on Relapse

Counseling Patients With Schizophrenia on Relapse

May 28th 2020
Challenges in Treating Schizophrenia

Challenges in Treating Schizophrenia

May 28th 2020
New Study Backs Ketamine as Treatment Option for Depression

New Study Backs Ketamine as Treatment Option for Depression

May 26th 2020

Investigators find a greater increase in positive symptoms after a ketamine infusion when compared to placebo.

Recommendations for Using LAIs During COVID-19

Recommendations for Using LAIs During COVID-19

May 21st 2020
Early Initiation of LAIs in Treating Schizophrenia

Early Initiation of LAIs in Treating Schizophrenia

May 21st 2020
Overcoming Barriers With LAIs in Schizophrenia Management

Overcoming Barriers With LAIs in Schizophrenia Management

May 21st 2020
Management of Schizophrenia and Available LAIs

Management of Schizophrenia and Available LAIs

May 21st 2020
Initiating LAI Therapy for the Treatment of Schizophrenia

Initiating LAI Therapy for the Treatment of Schizophrenia

May 21st 2020
Switching From Oral Therapy to Long-Acting Injectables

Switching From Oral Therapy to Long-Acting Injectables

May 21st 2020
<123456789
...
16>
© 2024 MJH Life Sciences

All rights reserved.